Skip to main content

and
  1. No Access

    Protocol

    Probing the Antigenicity of HCV Envelope Glycoproteins by Phage Display Antibody Technology

    The envelope glycoproteins E1 and E2 of hepatitis C virus form a heterodimeric complex on the viral surface. They are the targets of neutralizing antibodies and are being investigated as potential vaccine anti...

    Erick Giang, Fernando Aleman, Mansun Law in Hepatitis C Virus Protocols (2019)

  2. No Access

    Protocol

    Simultaneous Quantification of Hepatitis C Virus Envelope Glycoproteins E1 and E2 by Dual-Color Fluorescence Immunoblot Analysis

    The hepatitis C virus (HCV) envelope glycoproteins, E1 and E2, are crucial for HCV assembly and entry, and are promising vaccine antigens. However, they are challenging to study because of technical difficulti...

    Fang Chen, Erick Giang, Radhika Gopal, Mansun Law in Hepatitis C Virus Protocols (2019)